Avid Radiopharmaceuticals, Inc.
Pharmaceutical company · Philadelphia, Pennsylvania, United States
Avid Radiopharmaceuticals, Inc. is a pharmaceutical company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2004. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $2.2 million in total, most recently in 2008. It has reported private securities offerings to the US SEC, most recently $35 million sold in a notice filed in 2009.
Avid Radiopharmaceuticals at a glance
What does Avid Radiopharmaceuticals do?
US government research funding
7 SBIR/STTR small-business research awards from US health agencies, $2.2 million in total (2005 to 2008).
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $34.5 million sold (2009).
Frequently asked questions about Avid Radiopharmaceuticals
Where is Avid Radiopharmaceuticals headquartered?
Avid Radiopharmaceuticals, Inc. is headquartered in Philadelphia, Pennsylvania, United States.
What does Avid Radiopharmaceuticals do?
Avid Radiopharmaceuticals, Inc. is a pharmaceutical company.
When was Avid Radiopharmaceuticals founded?
The earliest incorporation on record for Avid Radiopharmaceuticals, Inc. is in 2004, according to public company registers.
Similar companies
- Context Therapeutics Inc.Philadelphia, Pennsylvania, United States
- Lannett Co IncPhiladelphia, Pennsylvania, United States
- Carisma Therapeutics Inc.Philadelphia, Pennsylvania, United States
- EpiVario Inc.Philadelphia, Pennsylvania, United States
- Verismo Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Aro Biotherapeutics CoPhiladelphia, Pennsylvania, United States
- Alveus Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Mebias Discovery, Inc.Philadelphia, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences